Gene expression of kinin receptors B1 and B2 in PBMC from patients with cardiac syndrome X

Scandinavian Cardiovascular Journal

Volumn 41, Issue 6, 2007, Pages 391-396

  Dabek, Jozefa ^a   Wilczok, Tadeusz ^a   Gasior, Zbigniew ^a   Kucia Kuzma, Sylwia ^a   Twardowski, Romuald ^a   Kulach, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cardiac syndrome X; Gene expression; Kinin receptors; Mononuclear cells

Indexed keywords

KININ; KININ B1 RECEPTOR; KININ B2 RECEPTOR; MESSENGER RNA; RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC SYNDROME X; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART DISEASE; HUMAN; INFLAMMATION; MALE; NOCICEPTION; PAIN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ST SEGMENT DEPRESSION; THORAX PAIN; UNSTABLE ANGINA PECTORIS; VASOCONSTRICTION; VASODILATATION;

ADULT; AGED; CORONARY DISEASE; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; TRANSCRIPTION, GENETIC;

EID: 41649104859     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430701499379     Document Type: Article

References (25)

1. Kemp HG. Left ventricular function in patients with the anginal syndrome and normal coronary angiograms. Am J Cardiol. 1973;32:375-6.
2. Panting JR, Gatehause PD, Yang GZ, Grothues F. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346:1948-53.
3. Tyminska-Sedek K, Jakubowska-Najnigier M, Chory z kardiologicznym zespolem X. Terapia. 2002;9:z.2/2002.
4. Rogacka D, Wysocki H. Dlawica mikronaczyniowa i zaburzenia percepcji bólu jako glówne skladowe patogenetyczne kardiologicznego zespolu X. Folia Cardiol. 2003;10:553-61.
5. Kaski JC, Rosano GM, Collins P. Cardiac syndrome X: Clinical characteristics and left ventricular function long-term follow-up study. JACC. 1995;25:807-14.
6. Johnson BD, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institutes-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:2993-9.
7. Kolodziej K, Kasprzak JD. Kardiologiczny zespół X. Forum Kardiołogów. 2001;4:1425-3674.
8. Vazquez-Rey E, Kaski JC. Cardiovascular syndrome X and endothelial dysfunction. Rev Esp Cardiol. 2003;56:181-92.
9. Rosen SD, Paulesu E, Wise R, Camici P. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart. 2002;87:513-9.
10. Lanza GA, Crea F. The complex link between brain and heart in cardiac syndrome X. Heart. 2002;88:328-30.
11. Leu HB, Lin CP, Lin WT, Wu TC, Lin SJ, Chen JW. Circulating mononuclear superoxide production and inflammatory markers for long-term prognosis in patients with cardiac syndrome X. Free Radic Biol Med. 2006;40:983-91.
12. McLean PG, Perretti M, Ahluwalia A. Cardiovasc Res. Kinin B(1) receptors and the cardiovascular system: Regulation of expression and function. Cardiovasc Res. 2000;48:194-210.
13. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM. Kinin B1 receptors: Key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol. 2004;143:803-18.
14. Marceau F. Kinin B1 receptor: A review. Immunopharmacology. 1995;30:1-26.
15. Coelho MM, Oliveira CR, Pajolla GP, Calixto JB, Pela IR. Central involvement of kinin B1 and B2 receptors in the febrile response induced by endotoxin in rats. Br J Pharmacol. 1997;121:296-302.
16. Rajasekariah P, Warlow RS, Walls RS. High affinity bradykinin binding to human inflammatory cells. Biochem Mol Biol Int. 1997;43:279-90.
17. Drummond GR, Cocks TM. Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery. Br J Pharmacol. 1995;116:2473-81.
18. Paegelow I, Werner H, Reissmann S. Effects of bradykinin and bradykinin analogues on spleen cells of mice. Eur J Pharmacol. 1995;279:211-6.
19. Raidoo DM, Ramsaroop R, Naidoo S, Mueller-Esterl W, Bhoola KD. Kinin receptors in human vascular tissue: Their role in atheromatous disease. Immunopharmacology. 1997;36:153-60.
20. Lin CP, Lin WT, Leu HB, Wu TC, Chen JW. Differential mononuclear cell activity and endothelial inflammation in coronary artery disease and cardiac syndrome X. Int J Cardiol. 2003;89:53-62.
21. Leu HB, Lin CP, Lin WT, Wu TC, Lin SJ, Chen JW. Circulating mononuclear superoxide production and inflammatory markers for long-term prognosis in patients with cardiac syndrome X. Free Radic Biol Med. 2006;40:983-91.
22. Yang XP, Liu YH, Mehta D, Cavasin MA, Shesely E, Xu J, Liu F, Carretero OA. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice. Circ Res. 2001;88:1072-9.
23. Chen Z, Deddish PA, Minshall RD, Becker RP, Erdos EG, Tan F. Human ACE and bradykinin B2 receptors form a complex at the plasma membrane. FASEB J. 2006;20:2261-70.
24. Couture R, Harrison M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol. 2001;429:161-76.
25. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The Kallikrein-Kinin System: Current and future pharmacological targets. J Pharmacol Sci. 2005;99:6-38.